Danco Laboratories seeks Supreme Court stay of ruling pausing mail-order access to abortion drugs

An abortion rights activist holds a box of mifepristone during a rally in front of the US Supreme Court on March 26, 2024, in Washington, DC. The Court reenters the contentious legal battle over abortion on March 26 as it weighs restrictions on the drug that is most widely used in the US to terminate pregnancies. The conservative-dominated court, which overturned the constitutional right to abortion nearly two years ago, is to hear oral arguments on access to the abortion pill mifepristone. (Photo by Drew ANGERER / AFP) (Photo by DREW ANGERER/AFP via ) Drew Angerer | AFP | Pharmaceutical company Danco Laboratories filed an application with the U.S. Supreme Court on Saturday, asking for a stay of an appeals court ruling that temporarily blocks mail-order access to abortion drug mifepristone. On Friday, a U.S. appeals court temporarily blocked a federal rule allowing the abortion drug to be dispensed through the mail, significantly curtailing access to the drug nationwide and particularly in states that have banned abortion. A conservative three-judge panel of the New Orleans-based 5th U.S. Circuit Court of Appeals ruled unanimously that the Republican-led state of Louisiana was likely to prevail in its challenge to the 2023 rule adopted by Democratic former President Joe Biden's administration. …